Comprehensive Cell Solutions

Comprehensive Cell Solutions (CCS) is a distinguished business division of the New York Blood Center Enterprises, dedicated to addressing the needs of academic institutions, hospitals, biotechnology firms, pharmaceutical companies, and startup organisations. CCS facilitates the launch of new products and services and the execution of clinical trials by leveraging the extensive expertise and experience synonymous with NYBCe in clinical trials management and regulatory affairs. CCS strives to simplify complex clinical and research challenges while ensuring compliance with various accreditation standards.

Services include:
- Cell and Gene Therapy
- Regulatory Services
- Clinical trial management
- Budgeting and contract assistance
- IRB submission
- FDA submission
- Invoicing
- Consultation on FDA requirements and certifications
- Subject recruitment for clinical trials
- 'Ready to Ship' and 'Made to Order' products

Comprehensive Cell Solutions is rapidly positioning itself as a leading innovator in research and development focused on advanced blood and cell-based therapies that cater to critical, unmet patient needs. For further information, please visit nybc.org.